1. Academic Validation
  2. Biotransformation and activity identification of icariin in human intestinal fungus Pichia occidentalis

Biotransformation and activity identification of icariin in human intestinal fungus Pichia occidentalis

  • J Asian Nat Prod Res. 2025 May 21:1-12. doi: 10.1080/10286020.2025.2493937.
Jia-Shuo Li 1 Ru-Xin Yao 2 Qing Lv 3 Gang Wang 1 Xue Wang 2 Yu-Fei Wang 4 Fang-Yu Yang 4 Guo-Biao Liang 4 Zhuang Miao 5
Affiliations

Affiliations

  • 1 Graduate School, Dalian Medical University, Dalian116000, China.
  • 2 School of Pharmacy, Dalian Medical University, Dalian116000, China.
  • 3 Laboratory Animal Center, Dalian Medical University, Dalian116000, China.
  • 4 Institute of Neurology, General Hospital of Shenyang Military Command, Shenyang110000, China.
  • 5 Anesthesiology, The First Affiliated Hospital of Dalian Medical University, Dalian116000, China.
Abstract

Compared to icariin, icariside II demonstrates superior absorption and metabolic properties along with enhanced bioactivity. In this study, using DXM-Glc fluorescence assay, Pichia occidentalis was identified as an intestinal fungus expressing functional glucosidase, which could efficiently convert icariin to icariside II via glycosidic bond hydrolysis, revealing the fungus-mediated intestinal glycoside metabolism pathway and determining the optimal conditions for the conversion, including temperature, drug loading, pH and reaction time. Meanwhile, icariside II exhibited anti-glioma activity, and its mechanism of action involved the inhibition of the activation of NF-κB signaling pathway in glioma cells.

Keywords

Biotransformation; Pichia occidentalis; anti-tumour; fungi; icariside II.

Figures
Products